The evolving political landscape presents challenges for the health care sector, particularly with the potential for a Republican-controlled Congress.
Lawmakers will use the appropriations process to influence health care policy. Moving significant legislation may prove difficult, making budgetary decisions critical in shaping future health initiatives.
Collaboration with Congress is anticipated to be a key strategy for advancing health policy priorities under a Trump administration. The administration is likely to use budget reconciliation and the appropriations process to push its agenda.
The 119th Congress is expected to continue discussions and debates left unresolved by the previous session. Regulatory reform will be a focal point for a second Trump administration, with plans to modernize regulatory frameworks and reduce burdens at the Department of Health and Human Services (HHS).
President Trump is a vocal critic of the Affordable Care Act (ACA) and is likely to oppose the extension of enhanced premium subsidies. His administration is expected to support the expansion of short-term limited-duration insurance plans and promote regulatory flexibilities to increase access to care.
The opioid crisis and pro-life executive orders will remain significant focuses. Drug pricing policy reforms will continue to be a priority, with potential proposals to eliminate pharmaceutical rebates in Medicare Part D and establish an international reference pricing system for certain drugs.
Pharmacy benefit manager (PBM) reforms will also shape the discourse around prescription drug costs. Health innovation, including expedited access to medical advancements and the integration of artificial intelligence (AI) in health care, will be emphasized.
The approach to medical supply chains under a Trump administration will align with a "Buy American" initiative, aiming to reduce reliance on foreign suppliers, particularly China. A multiyear "national reshoring plan" will focus on essential medical products to enhance national security.
Monitoring political dynamics and health policy initiatives will be crucial for stakeholders in the health care sector. The future of health care in the United States will be shaped by the administration's agenda in a complex political environment.